Mark Lewis to Antiviral Agents
This is a "connection" page, showing publications Mark Lewis has written about Antiviral Agents.
Connection Strength
0.040
-
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nat Microbiol. 2021 09; 6(9):1188-1198.
Score: 0.022
-
TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy. Sci Transl Med. 2018 05 02; 10(439).
Score: 0.018